AngioDynamics

#Peripheral Vascular Disease #Interventional Oncology #Thrombus Management #Vascular Access

AngioDynamics, Inc. is a medical technology company that designs, manufactures and sells medical, surgical and diagnostic devices used to treat peripheral vascular disease and in oncology and surgical settings. Its portfolio includes the Auryon Atherectomy System, the AlphaVac and AngioVac thrombus-management platforms, the NanoKnife irreversible electroporation (IRE) ablation system, the Solero Microwave Tissue Ablation System and the VenaCure EVLT endovenous laser system. The company reported fiscal first-quarter 2027 results on October 8, 2026, beating on both adjusted EPS and revenue.

Company Info

Sector:Medical Devices / Vascular & Oncology

Headquarters:Latham, New York, United States

Founded:1988

Website:www.angiodynamics.com/

Upcoming Milestones & Key Dates

2026-10-08

Earnings

Reported fiscal Q1 2027 results (adjusted EPS -$0.04 vs -$0.11 consensus; revenue $80.9M vs $80.5M expected)

Clinical Development Pipeline

Auryon Atherectomy System

Target: Laser atherectomy platform

Peripheral arterial disease / lesion removal

Preclinical

Phase 1

Phase 2

Phase 3

Approved

AlphaVac / AngioVac

Target: Mechanical aspiration thrombectomy

Venous and arterial thrombus management

Preclinical

Phase 1

Phase 2

Phase 3

Approved

NanoKnife IRE System

Target: Irreversible electroporation

Soft-tissue surgical ablation

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Solero Microwave Tissue Ablation System

Target: Microwave thermal ablation

Soft-tissue tumour ablation

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

No recent news updates available for this company.

Leadership Team

James C. Clemmer

President, Chief Executive Officer and Director

Stephen A. Trowbridge

Executive Vice President and Chief Financial Officer

Careers & Job Openings

See all open roles

All departments

See posting

Apply Now →